nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—AOX1—Methotrexate—urinary bladder cancer	0.286	1	CbGbCtD
Aminocaproic Acid—PLG—prostate gland—urinary bladder cancer	0.0177	0.116	CbGeAlD
Aminocaproic Acid—PLAT—prostate gland—urinary bladder cancer	0.0151	0.0989	CbGeAlD
Aminocaproic Acid—Lipoic Acid—POR—urinary bladder cancer	0.0143	1	CrCbGaD
Aminocaproic Acid—PLG—epithelium—urinary bladder cancer	0.013	0.0855	CbGeAlD
Aminocaproic Acid—PLAT—seminal vesicle—urinary bladder cancer	0.0127	0.0837	CbGeAlD
Aminocaproic Acid—PLG—smooth muscle tissue—urinary bladder cancer	0.0125	0.0824	CbGeAlD
Aminocaproic Acid—PLG—renal system—urinary bladder cancer	0.0121	0.0793	CbGeAlD
Aminocaproic Acid—PLAT—urethra—urinary bladder cancer	0.0101	0.0662	CbGeAlD
Aminocaproic Acid—PLG—female reproductive system—urinary bladder cancer	0.00967	0.0635	CbGeAlD
Aminocaproic Acid—AOX1—prostate gland—urinary bladder cancer	0.00814	0.0535	CbGeAlD
Aminocaproic Acid—PLAT—vagina—urinary bladder cancer	0.00744	0.0488	CbGeAlD
Aminocaproic Acid—AOX1—seminal vesicle—urinary bladder cancer	0.00689	0.0452	CbGeAlD
Aminocaproic Acid—AOX1—renal system—urinary bladder cancer	0.00555	0.0364	CbGeAlD
Aminocaproic Acid—AOX1—urethra—urinary bladder cancer	0.00545	0.0358	CbGeAlD
Aminocaproic Acid—PLAT—lymph node—urinary bladder cancer	0.00481	0.0316	CbGeAlD
Aminocaproic Acid—PLAT—Blood Clotting Cascade—PLAU—urinary bladder cancer	0.00455	0.0163	CbGpPWpGaD
Aminocaproic Acid—PLG—Blood Clotting Cascade—PLAU—urinary bladder cancer	0.00455	0.0163	CbGpPWpGaD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.00444	0.016	CbGpPWpGaD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.00444	0.016	CbGpPWpGaD
Aminocaproic Acid—AOX1—female reproductive system—urinary bladder cancer	0.00444	0.0292	CbGeAlD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—BIRC3—urinary bladder cancer	0.00408	0.0147	CbGpPWpGaD
Aminocaproic Acid—AOX1—vagina—urinary bladder cancer	0.00402	0.0264	CbGeAlD
Aminocaproic Acid—PLG—Regulation of IGF Activity by IGFBP—IGF1—urinary bladder cancer	0.00384	0.0138	CbGpPWpGaD
Aminocaproic Acid—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.00381	0.0137	CbGpPWpGaD
Aminocaproic Acid—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.00371	0.0133	CbGpPWpGaD
Aminocaproic Acid—PLAT—Beta2 integrin cell surface interactions—PLAU—urinary bladder cancer	0.00365	0.0131	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—MPO—urinary bladder cancer	0.00362	0.013	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—MPO—urinary bladder cancer	0.00362	0.013	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—PLAU—urinary bladder cancer	0.00337	0.0121	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—PLAU—urinary bladder cancer	0.00337	0.0121	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00333	0.012	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.00287	0.0103	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.00287	0.0103	CbGpPWpGaD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.00279	0.01	CbGpPWpGaD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.00279	0.01	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—urinary bladder cancer	0.00271	0.00974	CbGpPWpGaD
Aminocaproic Acid—AOX1—lymph node—urinary bladder cancer	0.0026	0.0171	CbGeAlD
Aminocaproic Acid—PLG—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00252	0.00906	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—RHOA—urinary bladder cancer	0.00251	0.00903	CbGpPWpGaD
Aminocaproic Acid—PLG—Syndecan-4-mediated signaling events—RHOA—urinary bladder cancer	0.00251	0.00903	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—RHOA—urinary bladder cancer	0.00251	0.00903	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IGFBP3—urinary bladder cancer	0.00251	0.00902	CbGpPWpGaD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.00246	0.00883	CbGpPWpGaD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.00246	0.00883	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—SOD2—urinary bladder cancer	0.00227	0.00816	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—SOD2—urinary bladder cancer	0.00227	0.00816	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—GPX1—urinary bladder cancer	0.00217	0.00778	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—GPX1—urinary bladder cancer	0.00217	0.00778	CbGpPWpGaD
Aminocaproic Acid—PLG—Complement and Coagulation Cascades—PLAU—urinary bladder cancer	0.00207	0.00742	CbGpPWpGaD
Aminocaproic Acid—PLAT—Complement and Coagulation Cascades—PLAU—urinary bladder cancer	0.00207	0.00742	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—MTHFR—urinary bladder cancer	0.002	0.00718	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—MTHFR—urinary bladder cancer	0.002	0.00718	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—MMP9—urinary bladder cancer	0.002	0.00717	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.002	0.00717	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—MMP9—urinary bladder cancer	0.002	0.00717	CbGpPWpGaD
Aminocaproic Acid—PLG—Syndecan-4-mediated signaling events—MMP9—urinary bladder cancer	0.002	0.00717	CbGpPWpGaD
Aminocaproic Acid—PLAT—Endochondral Ossification—PLAU—urinary bladder cancer	0.00194	0.00695	CbGpPWpGaD
Aminocaproic Acid—PLAT—Endochondral Ossification—FGFR3—urinary bladder cancer	0.00188	0.00674	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.0018	0.00648	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.0018	0.00648	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.00172	0.00618	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.00172	0.00618	CbGpPWpGaD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—urinary bladder cancer	0.00161	0.00577	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00159	0.00571	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00159	0.00571	CbGpPWpGaD
Aminocaproic Acid—PLAT—Endochondral Ossification—IGF1—urinary bladder cancer	0.00158	0.00566	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—TNF—urinary bladder cancer	0.00154	0.00552	CbGpPWpGaD
Aminocaproic Acid—PLG—amb2 Integrin signaling—TNF—urinary bladder cancer	0.00154	0.00552	CbGpPWpGaD
Aminocaproic Acid—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.00153	0.00567	CcSEcCtD
Aminocaproic Acid—Nausea—Valrubicin—urinary bladder cancer	0.0015	0.00556	CcSEcCtD
Aminocaproic Acid—Pain—Mitomycin—urinary bladder cancer	0.00149	0.00552	CcSEcCtD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—urinary bladder cancer	0.00148	0.00532	CbGpPWpGaD
Aminocaproic Acid—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00144	0.00535	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00143	0.00532	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.00142	0.00528	CcSEcCtD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00142	0.0051	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00142	0.0051	CbGpPWpGaD
Aminocaproic Acid—Thrombosis—Epirubicin—urinary bladder cancer	0.00139	0.00518	CcSEcCtD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—urinary bladder cancer	0.00139	0.005	CbGpPWpGaD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—RHOA—urinary bladder cancer	0.00136	0.00489	CbGpPWpGaD
Aminocaproic Acid—Renal failure—Thiotepa—urinary bladder cancer	0.00135	0.005	CcSEcCtD
Aminocaproic Acid—Necrosis—Methotrexate—urinary bladder cancer	0.00134	0.00499	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00132	0.0049	CcSEcCtD
Aminocaproic Acid—PLG—Platelet degranulation—IGF1—urinary bladder cancer	0.00132	0.00474	CbGpPWpGaD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—PLAU—urinary bladder cancer	0.0013	0.00468	CbGpPWpGaD
Aminocaproic Acid—Muscular weakness—Fluorouracil—urinary bladder cancer	0.0013	0.00482	CcSEcCtD
Aminocaproic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—urinary bladder cancer	0.0013	0.00466	CbGpPWpGaD
Aminocaproic Acid—Thrombosis—Doxorubicin—urinary bladder cancer	0.00129	0.00479	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00128	0.00475	CcSEcCtD
Aminocaproic Acid—Necrosis—Epirubicin—urinary bladder cancer	0.00126	0.00467	CcSEcCtD
Aminocaproic Acid—PLG—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.00126	0.00451	CbGpPWpGaD
Aminocaproic Acid—Hallucination—Thiotepa—urinary bladder cancer	0.00122	0.00455	CcSEcCtD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—CDH1—urinary bladder cancer	0.00122	0.00437	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.00119	0.00442	CcSEcCtD
Aminocaproic Acid—PLAT—Folate Metabolism—IL2—urinary bladder cancer	0.00118	0.00425	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—IL2—urinary bladder cancer	0.00118	0.00425	CbGpPWpGaD
Aminocaproic Acid—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.00117	0.00421	CbGpPWpGaD
Aminocaproic Acid—Necrosis—Doxorubicin—urinary bladder cancer	0.00116	0.00432	CcSEcCtD
Aminocaproic Acid—Dizziness—Mitomycin—urinary bladder cancer	0.00115	0.00427	CcSEcCtD
Aminocaproic Acid—Tinnitus—Thiotepa—urinary bladder cancer	0.00115	0.00426	CcSEcCtD
Aminocaproic Acid—Delirium—Epirubicin—urinary bladder cancer	0.00115	0.00426	CcSEcCtD
Aminocaproic Acid—PLAT—Endochondral Ossification—MMP9—urinary bladder cancer	0.00115	0.00412	CbGpPWpGaD
Aminocaproic Acid—Renal failure—Gemcitabine—urinary bladder cancer	0.00113	0.00421	CcSEcCtD
Aminocaproic Acid—Vomiting—Mitomycin—urinary bladder cancer	0.00111	0.0041	CcSEcCtD
Aminocaproic Acid—Rash—Mitomycin—urinary bladder cancer	0.0011	0.00407	CcSEcCtD
Aminocaproic Acid—Dermatitis—Mitomycin—urinary bladder cancer	0.0011	0.00407	CcSEcCtD
Aminocaproic Acid—Headache—Mitomycin—urinary bladder cancer	0.00109	0.00404	CcSEcCtD
Aminocaproic Acid—PLG—Orphan transporters—CREBBP—urinary bladder cancer	0.00108	0.00389	CbGpPWpGaD
Aminocaproic Acid—PLAT—Orphan transporters—CREBBP—urinary bladder cancer	0.00108	0.00389	CbGpPWpGaD
Aminocaproic Acid—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00108	0.004	CcSEcCtD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—urinary bladder cancer	0.00108	0.00386	CbGpPWpGaD
Aminocaproic Acid—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00107	0.00398	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—RB1—urinary bladder cancer	0.00107	0.00385	CbGpPWpGaD
Aminocaproic Acid—Delirium—Doxorubicin—urinary bladder cancer	0.00106	0.00394	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—IGF1—urinary bladder cancer	0.00106	0.00381	CbGpPWpGaD
Aminocaproic Acid—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00106	0.00393	CcSEcCtD
Aminocaproic Acid—PLAT—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00106	0.0038	CbGpPWpGaD
Aminocaproic Acid—PLG—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00106	0.0038	CbGpPWpGaD
Aminocaproic Acid—Renal failure—Cisplatin—urinary bladder cancer	0.00106	0.00392	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Methotrexate—urinary bladder cancer	0.00105	0.00391	CcSEcCtD
Aminocaproic Acid—Nausea—Mitomycin—urinary bladder cancer	0.00103	0.00383	CcSEcCtD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00103	0.00368	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00103	0.00368	CbGpPWpGaD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.00101	0.00364	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.00101	0.00364	CbGpPWpGaD
Aminocaproic Acid—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.000991	0.00368	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Epirubicin—urinary bladder cancer	0.000987	0.00366	CcSEcCtD
Aminocaproic Acid—Bradycardia—Cisplatin—urinary bladder cancer	0.000983	0.00365	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Epirubicin—urinary bladder cancer	0.000981	0.00364	CcSEcCtD
Aminocaproic Acid—Renal failure—Etoposide—urinary bladder cancer	0.000968	0.00359	CcSEcCtD
Aminocaproic Acid—Leukopenia—Thiotepa—urinary bladder cancer	0.000959	0.00356	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—CDKN2A—urinary bladder cancer	0.000941	0.00338	CbGpPWpGaD
Aminocaproic Acid—Blood urea increased—Epirubicin—urinary bladder cancer	0.000932	0.00346	CcSEcCtD
Aminocaproic Acid—Convulsion—Thiotepa—urinary bladder cancer	0.000928	0.00345	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Etoposide—urinary bladder cancer	0.000919	0.00341	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Doxorubicin—urinary bladder cancer	0.000913	0.00339	CcSEcCtD
Aminocaproic Acid—Myalgia—Thiotepa—urinary bladder cancer	0.000912	0.00339	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Doxorubicin—urinary bladder cancer	0.000908	0.00337	CcSEcCtD
Aminocaproic Acid—Tinnitus—Cisplatin—urinary bladder cancer	0.0009	0.00334	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—CDX2—urinary bladder cancer	0.000894	0.00321	CbGpPWpGaD
Aminocaproic Acid—Confusional state—Thiotepa—urinary bladder cancer	0.000882	0.00327	CcSEcCtD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—MMP9—urinary bladder cancer	0.000881	0.00316	CbGpPWpGaD
Aminocaproic Acid—Blood urea increased—Doxorubicin—urinary bladder cancer	0.000862	0.0032	CcSEcCtD
Aminocaproic Acid—PLG—Folate Metabolism—TNF—urinary bladder cancer	0.000861	0.00309	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—TNF—urinary bladder cancer	0.000861	0.00309	CbGpPWpGaD
Aminocaproic Acid—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000856	0.00318	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—CXCL8—urinary bladder cancer	0.000853	0.00307	CbGpPWpGaD
Aminocaproic Acid—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000836	0.0031	CcSEcCtD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000836	0.003	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000836	0.003	CbGpPWpGaD
Aminocaproic Acid—Malaise—Gemcitabine—urinary bladder cancer	0.000813	0.00302	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—FGFR3—urinary bladder cancer	0.000813	0.00292	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—FGFR3—urinary bladder cancer	0.000813	0.00292	CbGpPWpGaD
Aminocaproic Acid—Leukopenia—Gemcitabine—urinary bladder cancer	0.000807	0.00299	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000797	0.00296	CcSEcCtD
Aminocaproic Acid—Leukopenia—Fluorouracil—urinary bladder cancer	0.000793	0.00294	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000791	0.00294	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.000781	0.0029	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00078	0.00289	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—CDKN1A—urinary bladder cancer	0.000769	0.00276	CbGpPWpGaD
Aminocaproic Acid—Convulsion—Fluorouracil—urinary bladder cancer	0.000768	0.00285	CcSEcCtD
Aminocaproic Acid—Myalgia—Gemcitabine—urinary bladder cancer	0.000767	0.00285	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—PTEN—urinary bladder cancer	0.000767	0.00276	CbGpPWpGaD
Aminocaproic Acid—PLG—Folate Metabolism—TP53—urinary bladder cancer	0.000759	0.00273	CbGpPWpGaD
Aminocaproic Acid—PLAT—Folate Metabolism—TP53—urinary bladder cancer	0.000759	0.00273	CbGpPWpGaD
Aminocaproic Acid—Discomfort—Gemcitabine—urinary bladder cancer	0.000758	0.00281	CcSEcCtD
Aminocaproic Acid—Malaise—Cisplatin—urinary bladder cancer	0.000758	0.00281	CcSEcCtD
Aminocaproic Acid—Myalgia—Fluorouracil—urinary bladder cancer	0.000755	0.0028	CcSEcCtD
Aminocaproic Acid—Leukopenia—Cisplatin—urinary bladder cancer	0.000752	0.00279	CcSEcCtD
Aminocaproic Acid—Pain—Thiotepa—urinary bladder cancer	0.000748	0.00278	CcSEcCtD
Aminocaproic Acid—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000748	0.00269	CbGpPWpGaD
Aminocaproic Acid—Discomfort—Fluorouracil—urinary bladder cancer	0.000746	0.00277	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00074	0.00275	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000736	0.00273	CcSEcCtD
Aminocaproic Acid—Oedema—Gemcitabine—urinary bladder cancer	0.000736	0.00273	CcSEcCtD
Aminocaproic Acid—PLG—p75(NTR)-mediated signaling—TP53—urinary bladder cancer	0.000733	0.00263	CbGpPWpGaD
Aminocaproic Acid—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.000731	0.00271	CcSEcCtD
Aminocaproic Acid—Confusional state—Fluorouracil—urinary bladder cancer	0.000729	0.00271	CcSEcCtD
Aminocaproic Acid—Convulsion—Cisplatin—urinary bladder cancer	0.000728	0.0027	CcSEcCtD
Aminocaproic Acid—Oedema—Fluorouracil—urinary bladder cancer	0.000723	0.00268	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000723	0.00268	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000721	0.00267	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00072	0.00267	CcSEcCtD
Aminocaproic Acid—Myalgia—Cisplatin—urinary bladder cancer	0.000715	0.00265	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000715	0.00265	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000714	0.00265	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—SRC—urinary bladder cancer	0.000711	0.00256	CbGpPWpGaD
Aminocaproic Acid—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000708	0.00263	CcSEcCtD
Aminocaproic Acid—Discomfort—Cisplatin—urinary bladder cancer	0.000707	0.00262	CcSEcCtD
Aminocaproic Acid—Malaise—Etoposide—urinary bladder cancer	0.000694	0.00258	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.000691	0.00257	CcSEcCtD
Aminocaproic Acid—Leukopenia—Etoposide—urinary bladder cancer	0.000689	0.00256	CcSEcCtD
Aminocaproic Acid—Hypotension—Gemcitabine—urinary bladder cancer	0.000687	0.00255	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000686	0.00255	CcSEcCtD
Aminocaproic Acid—Oedema—Cisplatin—urinary bladder cancer	0.000686	0.00255	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000685	0.00254	CcSEcCtD
Aminocaproic Acid—PLAT—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.000684	0.00246	CbGpPWpGaD
Aminocaproic Acid—PLG—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.000684	0.00246	CbGpPWpGaD
Aminocaproic Acid—Loss of consciousness—Etoposide—urinary bladder cancer	0.000677	0.00251	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000677	0.00251	CcSEcCtD
Aminocaproic Acid—Hypotension—Fluorouracil—urinary bladder cancer	0.000676	0.00251	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000671	0.00249	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00067	0.00249	CcSEcCtD
Aminocaproic Acid—Convulsion—Etoposide—urinary bladder cancer	0.000667	0.00248	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000659	0.00245	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000656	0.00243	CcSEcCtD
Aminocaproic Acid—Discomfort—Etoposide—urinary bladder cancer	0.000647	0.0024	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000645	0.00239	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000644	0.00239	CcSEcCtD
Aminocaproic Acid—Hypotension—Cisplatin—urinary bladder cancer	0.000641	0.00238	CcSEcCtD
Aminocaproic Acid—Confusional state—Etoposide—urinary bladder cancer	0.000633	0.00235	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Epirubicin—urinary bladder cancer	0.000632	0.00235	CcSEcCtD
Aminocaproic Acid—Pain—Gemcitabine—urinary bladder cancer	0.000629	0.00233	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000628	0.00233	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000625	0.00232	CcSEcCtD
Aminocaproic Acid—Pruritus—Thiotepa—urinary bladder cancer	0.000619	0.0023	CcSEcCtD
Aminocaproic Acid—Pain—Fluorouracil—urinary bladder cancer	0.000619	0.0023	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000615	0.00228	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Cisplatin—urinary bladder cancer	0.000611	0.00227	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000606	0.00225	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.000598	0.00222	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000596	0.00221	CcSEcCtD
Aminocaproic Acid—Hypotension—Etoposide—urinary bladder cancer	0.000587	0.00218	CcSEcCtD
Aminocaproic Acid—Pain—Cisplatin—urinary bladder cancer	0.000586	0.00218	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000585	0.0021	CbGpPWpGaD
Aminocaproic Acid—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000585	0.00217	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—GSTO2—urinary bladder cancer	0.00058	0.00208	CbGpPWpGaD
Aminocaproic Acid—Renal failure—Methotrexate—urinary bladder cancer	0.00058	0.00215	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—ERBB2—urinary bladder cancer	0.000579	0.00208	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—ERBB2—urinary bladder cancer	0.000579	0.00208	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Thiotepa—urinary bladder cancer	0.000578	0.00215	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000565	0.0021	CcSEcCtD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000565	0.00203	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000565	0.00203	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000561	0.00202	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Etoposide—urinary bladder cancer	0.00056	0.00208	CcSEcCtD
Aminocaproic Acid—Vomiting—Thiotepa—urinary bladder cancer	0.000556	0.00206	CcSEcCtD
Aminocaproic Acid—Rash—Thiotepa—urinary bladder cancer	0.000551	0.00205	CcSEcCtD
Aminocaproic Acid—Dermatitis—Thiotepa—urinary bladder cancer	0.000551	0.00204	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000551	0.00204	CcSEcCtD
Aminocaproic Acid—Headache—Thiotepa—urinary bladder cancer	0.000548	0.00203	CcSEcCtD
Aminocaproic Acid—Renal failure—Epirubicin—urinary bladder cancer	0.000543	0.00201	CcSEcCtD
Aminocaproic Acid—Pain—Etoposide—urinary bladder cancer	0.000537	0.00199	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.000536	0.00193	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000533	0.00198	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—TP53—urinary bladder cancer	0.000524	0.00188	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—IFNA2—urinary bladder cancer	0.000522	0.00187	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—IFNA2—urinary bladder cancer	0.000522	0.00187	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Gemcitabine—urinary bladder cancer	0.00052	0.00193	CcSEcCtD
Aminocaproic Acid—Nausea—Thiotepa—urinary bladder cancer	0.000519	0.00193	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.000518	0.00192	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000515	0.00191	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000514	0.00191	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—GSTZ1—urinary bladder cancer	0.000512	0.00184	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Fluorouracil—urinary bladder cancer	0.000512	0.0019	CcSEcCtD
Aminocaproic Acid—PLG—Extracellular matrix organization—CDH1—urinary bladder cancer	0.00051	0.00183	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000505	0.00188	CcSEcCtD
Aminocaproic Acid—Bradycardia—Epirubicin—urinary bladder cancer	0.000505	0.00187	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000503	0.00187	CcSEcCtD
Aminocaproic Acid—Renal failure—Doxorubicin—urinary bladder cancer	0.000502	0.00186	CcSEcCtD
Aminocaproic Acid—PLAT—Senescence and Autophagy in Cancer—HRAS—urinary bladder cancer	0.000501	0.0018	CbGpPWpGaD
Aminocaproic Acid—Abdominal pain—Etoposide—urinary bladder cancer	0.000497	0.00184	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—CDKN1A—urinary bladder cancer	0.000495	0.00178	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—CDKN1A—urinary bladder cancer	0.000495	0.00178	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000495	0.00184	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—PTEN—urinary bladder cancer	0.000494	0.00178	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—PTEN—urinary bladder cancer	0.000494	0.00178	CbGpPWpGaD
Aminocaproic Acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000494	0.00183	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—GSTO2—urinary bladder cancer	0.000486	0.00175	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NAT1—urinary bladder cancer	0.000486	0.00175	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Fluorouracil—urinary bladder cancer	0.000478	0.00178	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000477	0.00177	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000469	0.00174	CcSEcCtD
Aminocaproic Acid—Vomiting—Gemcitabine—urinary bladder cancer	0.000468	0.00174	CcSEcCtD
Aminocaproic Acid—Bradycardia—Doxorubicin—urinary bladder cancer	0.000467	0.00173	CcSEcCtD
Aminocaproic Acid—Rash—Gemcitabine—urinary bladder cancer	0.000464	0.00172	CcSEcCtD
Aminocaproic Acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.000463	0.00172	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Etoposide—urinary bladder cancer	0.000463	0.00172	CcSEcCtD
Aminocaproic Acid—Tinnitus—Epirubicin—urinary bladder cancer	0.000462	0.00172	CcSEcCtD
Aminocaproic Acid—Headache—Gemcitabine—urinary bladder cancer	0.000461	0.00171	CcSEcCtD
Aminocaproic Acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00046	0.00171	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—SRC—urinary bladder cancer	0.000458	0.00165	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—SRC—urinary bladder cancer	0.000458	0.00165	CbGpPWpGaD
Aminocaproic Acid—Rash—Fluorouracil—urinary bladder cancer	0.000456	0.00169	CcSEcCtD
Aminocaproic Acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.000456	0.00169	CcSEcCtD
Aminocaproic Acid—Headache—Fluorouracil—urinary bladder cancer	0.000453	0.00168	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—SLC19A1—urinary bladder cancer	0.000451	0.00162	CbGpPWpGaD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.00045	0.00162	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Etoposide—urinary bladder cancer	0.000444	0.00165	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—UGT2B7—urinary bladder cancer	0.000444	0.0016	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PRSS3—urinary bladder cancer	0.00044	0.00158	CbGpPWpGaD
Aminocaproic Acid—Nausea—Gemcitabine—urinary bladder cancer	0.000437	0.00162	CcSEcCtD
Aminocaproic Acid—Vomiting—Cisplatin—urinary bladder cancer	0.000436	0.00162	CcSEcCtD
Aminocaproic Acid—Rash—Cisplatin—urinary bladder cancer	0.000432	0.0016	CcSEcCtD
Aminocaproic Acid—Dermatitis—Cisplatin—urinary bladder cancer	0.000432	0.0016	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Etoposide—urinary bladder cancer	0.00043	0.0016	CcSEcCtD
Aminocaproic Acid—Nausea—Fluorouracil—urinary bladder cancer	0.00043	0.00159	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000428	0.00159	CcSEcCtD
Aminocaproic Acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000428	0.00159	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—HDAC4—urinary bladder cancer	0.000419	0.00151	CbGpPWpGaD
Aminocaproic Acid—Malaise—Methotrexate—urinary bladder cancer	0.000416	0.00154	CcSEcCtD
Aminocaproic Acid—Dizziness—Etoposide—urinary bladder cancer	0.000415	0.00154	CcSEcCtD
Aminocaproic Acid—Leukopenia—Methotrexate—urinary bladder cancer	0.000413	0.00153	CcSEcCtD
Aminocaproic Acid—Nausea—Cisplatin—urinary bladder cancer	0.000407	0.00151	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—HDAC4—urinary bladder cancer	0.000402	0.00144	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HDAC4—urinary bladder cancer	0.000402	0.00144	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—EGFR—urinary bladder cancer	0.000402	0.00144	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—EGFR—urinary bladder cancer	0.000402	0.00144	CbGpPWpGaD
Aminocaproic Acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.0004	0.00149	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—CYP4B1—urinary bladder cancer	0.0004	0.00144	CbGpPWpGaD
Aminocaproic Acid—Convulsion—Methotrexate—urinary bladder cancer	0.000399	0.00148	CcSEcCtD
Aminocaproic Acid—Vomiting—Etoposide—urinary bladder cancer	0.000399	0.00148	CcSEcCtD
Aminocaproic Acid—Rash—Etoposide—urinary bladder cancer	0.000396	0.00147	CcSEcCtD
Aminocaproic Acid—Dermatitis—Etoposide—urinary bladder cancer	0.000396	0.00147	CcSEcCtD
Aminocaproic Acid—Headache—Etoposide—urinary bladder cancer	0.000394	0.00146	CcSEcCtD
Aminocaproic Acid—Myalgia—Methotrexate—urinary bladder cancer	0.000393	0.00146	CcSEcCtD
Aminocaproic Acid—PLG—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000392	0.00141	CbGpPWpGaD
Aminocaproic Acid—Malaise—Epirubicin—urinary bladder cancer	0.000389	0.00144	CcSEcCtD
Aminocaproic Acid—Discomfort—Methotrexate—urinary bladder cancer	0.000388	0.00144	CcSEcCtD
Aminocaproic Acid—Syncope—Epirubicin—urinary bladder cancer	0.000387	0.00144	CcSEcCtD
Aminocaproic Acid—Leukopenia—Epirubicin—urinary bladder cancer	0.000386	0.00143	CcSEcCtD
Aminocaproic Acid—Confusional state—Methotrexate—urinary bladder cancer	0.000379	0.00141	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—KRAS—urinary bladder cancer	0.000379	0.00136	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—KRAS—urinary bladder cancer	0.000379	0.00136	CbGpPWpGaD
Aminocaproic Acid—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000379	0.00141	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—SLC19A1—urinary bladder cancer	0.000378	0.00136	CbGpPWpGaD
Aminocaproic Acid—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000376	0.0014	CcSEcCtD
Aminocaproic Acid—Convulsion—Epirubicin—urinary bladder cancer	0.000374	0.00139	CcSEcCtD
Aminocaproic Acid—Nausea—Etoposide—urinary bladder cancer	0.000373	0.00138	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00037	0.00137	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—PLAU—urinary bladder cancer	0.00037	0.00133	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—PLAU—urinary bladder cancer	0.00037	0.00133	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000369	0.00133	CbGpPWpGaD
Aminocaproic Acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000368	0.00137	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—PRSS3—urinary bladder cancer	0.000368	0.00132	CbGpPWpGaD
Aminocaproic Acid—Myalgia—Epirubicin—urinary bladder cancer	0.000367	0.00136	CcSEcCtD
Aminocaproic Acid—Discomfort—Epirubicin—urinary bladder cancer	0.000363	0.00135	CcSEcCtD
Aminocaproic Acid—Malaise—Doxorubicin—urinary bladder cancer	0.00036	0.00134	CcSEcCtD
Aminocaproic Acid—Syncope—Doxorubicin—urinary bladder cancer	0.000358	0.00133	CcSEcCtD
Aminocaproic Acid—Leukopenia—Doxorubicin—urinary bladder cancer	0.000357	0.00133	CcSEcCtD
Aminocaproic Acid—Confusional state—Epirubicin—urinary bladder cancer	0.000355	0.00132	CcSEcCtD
Aminocaproic Acid—Oedema—Epirubicin—urinary bladder cancer	0.000352	0.00131	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000352	0.00131	CcSEcCtD
Aminocaproic Acid—Hypotension—Methotrexate—urinary bladder cancer	0.000352	0.00131	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000351	0.0013	CcSEcCtD
Aminocaproic Acid—Shock—Epirubicin—urinary bladder cancer	0.000346	0.00129	CcSEcCtD
Aminocaproic Acid—Convulsion—Doxorubicin—urinary bladder cancer	0.000346	0.00128	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000345	0.00128	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000343	0.00127	CcSEcCtD
Aminocaproic Acid—Myalgia—Doxorubicin—urinary bladder cancer	0.00034	0.00126	CcSEcCtD
Aminocaproic Acid—PLG—Signaling Pathways—GLI1—urinary bladder cancer	0.000337	0.00121	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—GLI1—urinary bladder cancer	0.000337	0.00121	CbGpPWpGaD
Aminocaproic Acid—Discomfort—Doxorubicin—urinary bladder cancer	0.000336	0.00125	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Methotrexate—urinary bladder cancer	0.000335	0.00125	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—LIG1—urinary bladder cancer	0.000333	0.0012	CbGpPWpGaD
Aminocaproic Acid—Hypotension—Epirubicin—urinary bladder cancer	0.000329	0.00122	CcSEcCtD
Aminocaproic Acid—Confusional state—Doxorubicin—urinary bladder cancer	0.000329	0.00122	CcSEcCtD
Aminocaproic Acid—Oedema—Doxorubicin—urinary bladder cancer	0.000326	0.00121	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000326	0.00121	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—HRAS—urinary bladder cancer	0.000322	0.00116	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—HRAS—urinary bladder cancer	0.000322	0.00116	CbGpPWpGaD
Aminocaproic Acid—Pain—Methotrexate—urinary bladder cancer	0.000322	0.00119	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000321	0.00119	CcSEcCtD
Aminocaproic Acid—Shock—Doxorubicin—urinary bladder cancer	0.000321	0.00119	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000319	0.00118	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Epirubicin—urinary bladder cancer	0.000314	0.00117	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00031	0.00115	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000308	0.00114	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—CREBBP—urinary bladder cancer	0.000305	0.0011	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—CREBBP—urinary bladder cancer	0.000305	0.0011	CbGpPWpGaD
Aminocaproic Acid—Hypotension—Doxorubicin—urinary bladder cancer	0.000304	0.00113	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—IGF1—urinary bladder cancer	0.000301	0.00108	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—IGF1—urinary bladder cancer	0.000301	0.00108	CbGpPWpGaD
Aminocaproic Acid—Pain—Epirubicin—urinary bladder cancer	0.000301	0.00112	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.000297	0.0011	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000297	0.0011	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—TYMP—urinary bladder cancer	0.000294	0.00106	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00029	0.00108	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00029	0.00108	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000288	0.00107	CcSEcCtD
Aminocaproic Acid—Pain—Doxorubicin—urinary bladder cancer	0.000279	0.00103	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.000278	0.00103	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000277	0.00103	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—RHOA—urinary bladder cancer	0.000276	0.000992	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—RHOA—urinary bladder cancer	0.000276	0.000992	CbGpPWpGaD
Aminocaproic Acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000269	0.000997	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000266	0.000989	CcSEcCtD
Aminocaproic Acid—Pruritus—Methotrexate—urinary bladder cancer	0.000266	0.000988	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—NAT2—urinary bladder cancer	0.000266	0.000956	CbGpPWpGaD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000264	0.00095	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000264	0.00095	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000259	0.000963	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000258	0.000956	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000257	0.000956	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—ENO2—urinary bladder cancer	0.000254	0.000913	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Epirubicin—urinary bladder cancer	0.000249	0.000925	CcSEcCtD
Aminocaproic Acid—Dizziness—Methotrexate—urinary bladder cancer	0.000249	0.000924	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000241	0.000894	CcSEcCtD
Aminocaproic Acid—AOX1—Disease—RBX1—urinary bladder cancer	0.000241	0.000865	CbGpPWpGaD
Aminocaproic Acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00024	0.000891	CcSEcCtD
Aminocaproic Acid—Vomiting—Methotrexate—urinary bladder cancer	0.000239	0.000888	CcSEcCtD
Aminocaproic Acid—Rash—Methotrexate—urinary bladder cancer	0.000237	0.000881	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—IGF1—urinary bladder cancer	0.000237	0.000852	CbGpPWpGaD
Aminocaproic Acid—Dermatitis—Methotrexate—urinary bladder cancer	0.000237	0.00088	CcSEcCtD
Aminocaproic Acid—Headache—Methotrexate—urinary bladder cancer	0.000236	0.000875	CcSEcCtD
Aminocaproic Acid—Dizziness—Epirubicin—urinary bladder cancer	0.000233	0.000864	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—IL2—urinary bladder cancer	0.000232	0.000833	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—IL2—urinary bladder cancer	0.000232	0.000833	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—RBX1—urinary bladder cancer	0.000231	0.000829	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—RBX1—urinary bladder cancer	0.000231	0.000829	CbGpPWpGaD
Aminocaproic Acid—Pruritus—Doxorubicin—urinary bladder cancer	0.000231	0.000856	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—RRM2—urinary bladder cancer	0.00023	0.000826	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Epirubicin—urinary bladder cancer	0.000224	0.000831	CcSEcCtD
Aminocaproic Acid—Nausea—Methotrexate—urinary bladder cancer	0.000224	0.00083	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000223	0.000827	CcSEcCtD
Aminocaproic Acid—Rash—Epirubicin—urinary bladder cancer	0.000222	0.000824	CcSEcCtD
Aminocaproic Acid—Dermatitis—Epirubicin—urinary bladder cancer	0.000222	0.000823	CcSEcCtD
Aminocaproic Acid—Headache—Epirubicin—urinary bladder cancer	0.000221	0.000819	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—TSC1—urinary bladder cancer	0.000217	0.000779	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TSC1—urinary bladder cancer	0.000217	0.000779	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—JAG1—urinary bladder cancer	0.000216	0.000775	CbGpPWpGaD
Aminocaproic Acid—Dizziness—Doxorubicin—urinary bladder cancer	0.000215	0.0008	CcSEcCtD
Aminocaproic Acid—AOX1—Metabolism—ENO2—urinary bladder cancer	0.000213	0.000765	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HPGDS—urinary bladder cancer	0.000213	0.000765	CbGpPWpGaD
Aminocaproic Acid—Nausea—Epirubicin—urinary bladder cancer	0.000209	0.000776	CcSEcCtD
Aminocaproic Acid—PLAT—Hemostasis—EP300—urinary bladder cancer	0.000208	0.000747	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—EP300—urinary bladder cancer	0.000208	0.000747	CbGpPWpGaD
Aminocaproic Acid—Vomiting—Doxorubicin—urinary bladder cancer	0.000207	0.000769	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—JAG1—urinary bladder cancer	0.000206	0.000742	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—JAG1—urinary bladder cancer	0.000206	0.000742	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GSTT1—urinary bladder cancer	0.000206	0.000742	CbGpPWpGaD
Aminocaproic Acid—Rash—Doxorubicin—urinary bladder cancer	0.000205	0.000762	CcSEcCtD
Aminocaproic Acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.000205	0.000762	CcSEcCtD
Aminocaproic Acid—Headache—Doxorubicin—urinary bladder cancer	0.000204	0.000758	CcSEcCtD
Aminocaproic Acid—PLG—Hemostasis—SRC—urinary bladder cancer	0.000202	0.000726	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—SRC—urinary bladder cancer	0.000202	0.000726	CbGpPWpGaD
Aminocaproic Acid—Nausea—Doxorubicin—urinary bladder cancer	0.000194	0.000718	CcSEcCtD
Aminocaproic Acid—PLG—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000191	0.000685	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NQO1—urinary bladder cancer	0.000172	0.000616	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—KRAS—urinary bladder cancer	0.000167	0.000602	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—KRAS—urinary bladder cancer	0.000167	0.000602	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—S100B—urinary bladder cancer	0.000167	0.000601	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—S100B—urinary bladder cancer	0.000167	0.000601	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—NCOR1—urinary bladder cancer	0.000157	0.000564	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—NCOR1—urinary bladder cancer	0.00015	0.00054	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—NCOR1—urinary bladder cancer	0.00015	0.00054	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—TP53—urinary bladder cancer	0.000149	0.000535	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—TP53—urinary bladder cancer	0.000149	0.000535	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—ERCC2—urinary bladder cancer	0.000148	0.00053	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GSTP1—urinary bladder cancer	0.000143	0.000514	CbGpPWpGaD
Aminocaproic Acid—PLG—Hemostasis—HRAS—urinary bladder cancer	0.000142	0.000511	CbGpPWpGaD
Aminocaproic Acid—PLAT—Hemostasis—HRAS—urinary bladder cancer	0.000142	0.000511	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MTHFR—urinary bladder cancer	0.000139	0.000498	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—TERT—urinary bladder cancer	0.000138	0.000497	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—TYMS—urinary bladder cancer	0.000133	0.000478	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TERT—urinary bladder cancer	0.000132	0.000476	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TERT—urinary bladder cancer	0.000132	0.000476	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—NCOR1—urinary bladder cancer	0.000131	0.000472	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GSTM1—urinary bladder cancer	0.000131	0.000472	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—FGFR3—urinary bladder cancer	0.000127	0.000456	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—GPX1—urinary bladder cancer	0.000126	0.000452	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—ERCC2—urinary bladder cancer	0.000124	0.000444	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—FGFR3—urinary bladder cancer	0.000122	0.000437	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—FGFR3—urinary bladder cancer	0.000122	0.000437	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ESR1—urinary bladder cancer	0.000118	0.000424	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ESR1—urinary bladder cancer	0.000118	0.000424	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—MTHFR—urinary bladder cancer	0.000116	0.000417	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CREBBP—urinary bladder cancer	0.000108	0.000388	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CREBBP—urinary bladder cancer	0.000104	0.000372	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CREBBP—urinary bladder cancer	0.000104	0.000372	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IGF1—urinary bladder cancer	0.000102	0.000367	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IGF1—urinary bladder cancer	0.000102	0.000367	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—RHOA—urinary bladder cancer	9.78e-05	0.000351	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PPARG—urinary bladder cancer	9.42e-05	0.000339	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—RHOA—urinary bladder cancer	9.36e-05	0.000336	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—RHOA—urinary bladder cancer	9.36e-05	0.000336	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—CREBBP—urinary bladder cancer	9.05e-05	0.000325	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—ERBB2—urinary bladder cancer	9.05e-05	0.000325	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PTGS2—urinary bladder cancer	8.85e-05	0.000318	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—ERBB2—urinary bladder cancer	8.67e-05	0.000311	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—ERBB2—urinary bladder cancer	8.67e-05	0.000311	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CXCL8—urinary bladder cancer	8.22e-05	0.000295	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CXCL8—urinary bladder cancer	8.22e-05	0.000295	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—IL2—urinary bladder cancer	7.86e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—IL2—urinary bladder cancer	7.86e-05	0.000282	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—CDKN1A—urinary bladder cancer	7.74e-05	0.000278	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—PTEN—urinary bladder cancer	7.72e-05	0.000277	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CCND1—urinary bladder cancer	7.66e-05	0.000275	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CCND1—urinary bladder cancer	7.66e-05	0.000275	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MMP9—urinary bladder cancer	7.44e-05	0.000267	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MMP9—urinary bladder cancer	7.44e-05	0.000267	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PTGS2—urinary bladder cancer	7.41e-05	0.000266	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—CDKN1A—urinary bladder cancer	7.41e-05	0.000266	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—CDKN1A—urinary bladder cancer	7.41e-05	0.000266	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—PTEN—urinary bladder cancer	7.39e-05	0.000266	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—PTEN—urinary bladder cancer	7.39e-05	0.000266	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EP300—urinary bladder cancer	7.36e-05	0.000264	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—SRC—urinary bladder cancer	7.16e-05	0.000257	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EP300—urinary bladder cancer	7.05e-05	0.000253	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EP300—urinary bladder cancer	7.05e-05	0.000253	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—SRC—urinary bladder cancer	6.85e-05	0.000246	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—SRC—urinary bladder cancer	6.85e-05	0.000246	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—PTEN—urinary bladder cancer	6.46e-05	0.000232	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—MYC—urinary bladder cancer	6.41e-05	0.00023	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—EGFR—urinary bladder cancer	6.27e-05	0.000225	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—EP300—urinary bladder cancer	6.16e-05	0.000221	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—MYC—urinary bladder cancer	6.14e-05	0.000221	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—MYC—urinary bladder cancer	6.14e-05	0.000221	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—EGFR—urinary bladder cancer	6.01e-05	0.000216	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—EGFR—urinary bladder cancer	6.01e-05	0.000216	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—KRAS—urinary bladder cancer	5.93e-05	0.000213	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KRAS—urinary bladder cancer	5.68e-05	0.000204	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KRAS—urinary bladder cancer	5.68e-05	0.000204	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—TP53—urinary bladder cancer	5.04e-05	0.000181	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—TP53—urinary bladder cancer	5.04e-05	0.000181	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—HRAS—urinary bladder cancer	5.04e-05	0.000181	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—HRAS—urinary bladder cancer	4.82e-05	0.000173	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—HRAS—urinary bladder cancer	4.82e-05	0.000173	CbGpPWpGaD
